Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies
Journal of Inflammation Research · 2026-09 · Volume 19 · 1-17
DOI: 10.2147/jir.s632705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-09. Verfasst von Maosen Dou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, …. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, People's Republic of China.
ORCID-Profile: Min Zhang
Zitieren
APA
Dou, M., Zhang, X., & Zhang, M. (2026). Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies. Journal of Inflammation Research, Volume 19, 1-17. https://doi.org/10.2147/jir.s632705
Vancouver
Dou M, Zhang X, Zhang M. Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies. Journal of Inflammation Research. 2026;Volume 19:1-17. doi:10.2147/jir.s632705
BibTeX
@article{Dou2026,
author = {Dou, Maosen and Zhang, Xue and Zhang, Min},
title = {Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--17},
doi = {10.2147/jir.s632705}
}
EUVIMED